eikontx.comHealthcare / BioTech & PharmaFounded: 2019Funding to Date: $2.42B
Eikon Therapeutics is a drug discovery and development business focused on the movements of single proteins within cells. Eikon's proprietary microscopes can visualize the movement within these cells. Eikon Therapeutics was founded in 2019 by Luke Lavis, Robert Tjian Ph.D., Xavier Darzacq Ph.D., and Eric Betzig and is headquartered in Hayward, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/16/2023 | Series C | $535MM | $xx.xx | $4.74B | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
24,884,830
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
Undisclosed Investors
|
||||||
01/06/2022 | Series B | $525MM | $xx.xx | $3.1B | T. Rowe Price Associates, Inc., Canada Pension Plan Investment Board, EcoR1 Capital, UC Investments, ADIA, StepStone Group, Soros Capital, Schroders Capital, Harel Insurance, General Catalyst, E15 VC, Hartford HealthCare Endowment, AME Cloud Ventures, The Column Group, Foresite Capital, Innovaction Endeavors, Lux Capital, Horizon Ventures | |
Price per Share
$xx.xx
Shares Outstanding
29,680,164
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
T. Rowe Price Associates, Inc., Canada Pension Plan Investment Board, EcoR1 Capital, UC Investments, ADIA, StepStone Group, Soros Capital, Schroders Capital, Harel Insurance, General Catalyst, E15 VC, Hartford HealthCare Endowment, AME Cloud Ventures, The Column Group, Foresite Capital, Innovaction Endeavors, Lux Capital, Horizon Ventures
|
||||||
05/05/2021 | Series A-1 | $102.54MM | $xx.xx | $248.17MM | The Column Group, Foresite Capital, Innovation Endeavors, Lux Capital | |
Price per Share
$xx.xx
Shares Outstanding
51,268,891
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
The Column Group, Foresite Capital, Innovation Endeavors, Lux Capital
|
||||||
05/05/2021 | Series A | $48MM | $xx.xx | $248.17MM | The Column Group, Foresite Capital, Innovation Endeavors, Lux Capital | |
Price per Share
$xx.xx
Shares Outstanding
48,000,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000.0
Key Investors
The Column Group, Foresite Capital, Innovation Endeavors, Lux Capital
|